Bal Pharma consolidated net profit rises 9.47% in the September 2024 quarter

Net profit of Bal Pharma rose 9.47% to Rs 1.04 crore in the quarter ended September 2024 as against Rs 0.95 crore during the previous quarter ended September 2023. Sales declined 20.37% to Rs 73.69 crore in the quarter ended September 2024 as against Rs 92.54 crore during the previous quarter ended September 2023.

Particulars	Quarter Ended
	Sep. 2024	Sep. 2023	% Var.
Sales	73.69	92.54	-20
OPM %	10.44	8.32	-
PBDT	3.84	4.02	-4
PBT	1.36	1.60	-15
NP	1.04	0.95	9